QuantLogix ← GEHC scorecard
📅 GEHC Earnings Preview
GE HealthCare Technologies Inc. Common Stock
Next report (est.)
10/26/2026
Countdown
Imminent
EPS growth YoY
-30.9%
Revenue growth YoY
+7.4%
Options-implied earnings move
±7.2%
The at-the-money straddle prices a move to roughly $77.13 or $66.83 from $71.98 by 10/30/2026.
Implied vs actual — last 8 reports
ReportOptions impliedActual moveMarket was
04/29/2026 ±2.9% -13.2% under-priced
02/04/2026 ±2.3% +4.9% under-priced
10/29/2025 ±1.8% -2.5% under-priced
07/30/2025 ±2.0% -7.8% under-priced
04/30/2025 ±4.3% +3.3% over-priced
02/13/2025 ±2.2% +8.8% under-priced
10/30/2024 ±2.4% +2.3% over-priced
07/31/2024 ±2.4% +2.4% over-priced
Across these reports, options implied an average ±2.5% move vs an actual average of 5.7% — the stock stayed inside the implied band 38% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q1 FY2026 $0.85 $5.1B $389M
Q4 FY2025 — $5.7B $588M
Q3 FY2025 $0.98 $5.1B $446M
Q2 FY2025 $1.06 $5.0B $486M
Analyst posture
Buy / Strong Buy
20
Hold
7
Sell
0
Stable: +1 net change 30d
Live 5-factor engine read: Buy · 74/100 Full scorecard →
Get alerted before every GEHC report — free Full live analysis
🤖 Pro runs a 10-agent AI debate on GEHC before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

GE HealthCare Technologies Inc. Common Stock (GEHC) reports imminently, with the next report estimated for 10/26/2026. Across the last 8 reports, options priced an average ±2.5% earnings move while the stock actually moved 5.7% on average — the market has been roughly fair on GEHC's earnings risk. Fundamentals into the print: EPS down 30.9% year-over-year, revenue up 7.4%. QuantLogix's live 5-factor engine currently reads GEHC as a buy at 74/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →